Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome
Completed
University of Virginia
N/A
2000-01-01
OBJECTIVES:
I. Determine whether reduction of serum insulin levels by metformin increases ovulatory
response to clomiphene citrate in women with polycystic ovary syndrome.
Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome
Completed
National Center for Research Resources (NCRR)
N/A
2000-01-01
OBJECTIVES:
I. Determine whether reduction of serum insulin levels by metformin increases ovulatory
response to clomiphene citrate in women with polycystic ovary syndrome.
Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome
Completed
University of Virginia
N/A
2000-01-01
OBJECTIVES:
I. Determine whether reduction of serum insulin levels by metformin increases ovulatory
response to clomiphene or spontaneous ovulation in obese women with polycystic ovary
syndrome.
Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome
Completed
National Center for Research Resources (NCRR)
N/A
2000-01-01
OBJECTIVES:
I. Determine whether reduction of serum insulin levels by metformin increases ovulatory
response to clomiphene or spontaneous ovulation in obese women with polycystic ovary
syndrome.
Treatment of Infertility in Women With Polycystic Ovary Syndrome
Completed
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase 3
2002-11-01
Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 10% of women.
The primary symptoms of PCOS are menstrual irregularities, increased body and facial hair,
acne, and infertility. This study will test a combination of medications in women with PCOS
to determine which works best to overcome infertility.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
